Show simple item record

FieldValueLanguage
dc.contributor.authorTendal, Brittaen_AU
dc.contributor.authorVogel, Joshua P.en_AU
dc.contributor.authorMcDonald, Steveen_AU
dc.contributor.authorNorris, Sarahen_AU
dc.contributor.authorCumpston, Mirandaen_AU
dc.contributor.authorWhite, Heathen_AU
dc.contributor.authorLeder, Karinen_AU
dc.contributor.authorNavarro, David Fraileen_AU
dc.contributor.authorCheyne, Saskiaen_AU
dc.contributor.authorChakraborty, Samanthaen_AU
dc.contributor.authorMurano, Melissaen_AU
dc.contributor.authorMillard, Tanyaen_AU
dc.contributor.authorCallesen, Henriette E.en_AU
dc.contributor.authorIslam, Rakibul M.en_AU
dc.contributor.authorElliott, Julianen_AU
dc.contributor.authorTurner, Tarien_AU
dc.date.accessioned2020-12-21
dc.date.available2020-12-21
dc.date.issued2021en_AU
dc.identifier.urihttps://hdl.handle.net/2123/24206
dc.description.abstractBACKGROUND: The Australian National COVID-19 Clinical Evidence Taskforce is a consortium of 31 Australian health professional organisations developing living, evidence-based guidelines for care of people with COVID-19 which are updated weekly. This paper describes the methods used to develop and maintain the guidelines. METHODS: The guidelines use GRADE methods and are designed to meet Australian NHMRC standards. Each week, new evidence is reviewed, current recommendations are revised and new recommendations made. These are published in MAGIC and disseminated through traditional and social media. Relevant new questions to be addressed are continually sought from stakeholders and practitioners. For prioritised questions, the evidence is actively monitored and updated. Evidence surveillance combines horizon scans and targeted searches. An Evidence Team appraises and synthesises evidence and prepares evidence-to-decision frameworks to inform development of recommendations. A Guidelines Leadership Group oversees the development of recommendations by multidisciplinary Guidelines Panels and is advised by a Consumer Panel. RESULTS: and Discussion: The Taskforce formed in March 2020, and the first recommendations were published two weeks later. The guidelines have been revised and republished on a weekly basis for 24 weeks, and as of October 2020 contain over 90 treatment recommendations, suggesting that living methods are feasible in this context. CONCLUSIONS: The Australian Guidelines for Care of People with COVID-19 provide an example of the feasibility of living guidelines, and an opportunity to test and improve living evidence methods.en_AU
dc.language.isoenen_AU
dc.subjectCOVID-19en_AU
dc.subjectCoronavirusen_AU
dc.titleWeekly updates of national living evidence-based guidelines: Methods for the Australian Living Guidelines for Care of People with COVID-19en_AU
dc.typeArticleen_AU
dc.identifier.doi10.1016/j.jclinepi.2020.11.005
dc.relation.otherDSF Charitable Foundation, DSFCF Australian Association of Gerontology, AAG Australian College of Critical Care Nurses, ACCCN Australian and New Zealand Society for Geriatric Medicine, ANZSGM Royal Australasian College of Surgeons, RACS Australasian Society for Infectious Diseases, ASID Department of Health and Human Services, State Government of Victoria, DHHS Equity Trustees Ian Potter Foundation, IPF Australian Association for Academic Primary Care, AAAPC Australasian Sleep Association, ASA Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists, ASCEPT Australian and New Zealand College of Anaesthetists, ANZCA Australian Society of Anaesthetists, ASA Royal Australasian College of Physicians, RACP Department of Health, Australian Governmenten_AU


Show simple item record

Associated file/s

There are no files associated with this item.

Associated collections

Show simple item record

There are no previous versions of the item available.